BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26406598)

  • 1. High Throughput Kinomic Profiling of Human Clear Cell Renal Cell Carcinoma Identifies Kinase Activity Dependent Molecular Subtypes.
    Anderson JC; Willey CD; Mehta A; Welaya K; Chen D; Duarte CW; Ghatalia P; Arafat W; Madan A; Sudarshan S; Naik G; Grizzle WE; Choueiri TK; Sonpavde G
    PLoS One; 2015; 10(9):e0139267. PubMed ID: 26406598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.
    Maruschke M; Reuter D; Koczan D; Hakenberg OW; Thiesen HJ
    BJU Int; 2011 Jul; 108(2 Pt 2):E29-35. PubMed ID: 21435154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinomic profiling identifies focal adhesion kinase 1 as a therapeutic target in advanced clear cell renal cell carcinoma.
    Ghosh AP; Willey CD; Anderson JC; Welaya K; Chen D; Mehta A; Ghatalia P; Madan A; Naik G; Sudarshan S; Sonpavde G
    Oncotarget; 2017 Apr; 8(17):29220-29232. PubMed ID: 28418903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene signatures of progression and metastasis in renal cell cancer.
    Jones J; Otu H; Spentzos D; Kolia S; Inan M; Beecken WD; Fellbaum C; Gu X; Joseph M; Pantuck AJ; Jonas D; Libermann TA
    Clin Cancer Res; 2005 Aug; 11(16):5730-9. PubMed ID: 16115910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microarray gene expression profiling and analysis in renal cell carcinoma.
    Liou LS; Shi T; Duan ZH; Sadhukhan P; Der SD; Novick AA; Hissong J; Skacel M; Almasan A; DiDonato JA
    BMC Urol; 2004 Jun; 4():9. PubMed ID: 15212686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional profiles in peripheral blood mononuclear cells prognostic of clinical outcomes in patients with advanced renal cell carcinoma.
    Burczynski ME; Twine NC; Dukart G; Marshall B; Hidalgo M; Stadler WM; Logan T; Dutcher J; Hudes G; Trepicchio WL; Strahs A; Immermann F; Slonim DK; Dorner AJ
    Clin Cancer Res; 2005 Feb; 11(3):1181-9. PubMed ID: 15709187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of genes and pathways involved in kidney renal clear cell carcinoma.
    Yang W; Yoshigoe K; Qin X; Liu JS; Yang JY; Niemierko A; Deng Y; Liu Y; Dunker A; Chen Z; Wang L; Xu D; Arabnia HR; Tong W; Yang M
    BMC Bioinformatics; 2014; 15 Suppl 17(Suppl 17):S2. PubMed ID: 25559354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT-PCR mRNA expression profile.
    Baldewijns MM; Thijssen VL; Van den Eynden GG; Van Laere SJ; Bluekens AM; Roskams T; van Poppel H; De Bruïne AP; Griffioen AW; Vermeulen PB
    Br J Cancer; 2007 Jun; 96(12):1888-95. PubMed ID: 17505508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular subclassification of kidney tumors and the discovery of new diagnostic markers.
    Takahashi M; Yang XJ; Sugimura J; Backdahl J; Tretiakova M; Qian CN; Gray SG; Knapp R; Anema J; Kahnoski R; Nicol D; Vogelzang NJ; Furge KA; Kanayama H; Kagawa S; Teh BT
    Oncogene; 2003 Oct; 22(43):6810-8. PubMed ID: 14555994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic profiling identifies alterations in TGFbeta signaling through loss of TGFbeta receptor expression in human renal cell carcinogenesis and progression.
    Copland JA; Luxon BA; Ajani L; Maity T; Campagnaro E; Guo H; LeGrand SN; Tamboli P; Wood CG
    Oncogene; 2003 Sep; 22(39):8053-62. PubMed ID: 12970754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression profiling of renal epithelial neoplasms: a method for tumor classification and discovery of diagnostic molecular markers.
    Young AN; Amin MB; Moreno CS; Lim SD; Cohen C; Petros JA; Marshall FF; Neish AS
    Am J Pathol; 2001 May; 158(5):1639-51. PubMed ID: 11337362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential protein profiling in renal-cell carcinoma.
    Shi T; Dong F; Liou LS; Duan ZH; Novick AC; DiDonato JA
    Mol Carcinog; 2004 May; 40(1):47-61. PubMed ID: 15108329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of HNF-1B in renal cell carcinoma is associated with tumor progression and poor prognosis.
    Buchner A; Castro M; Hennig A; Popp T; Assmann G; Stief CG; Zimmermann W
    Urology; 2010 Aug; 76(2):507.e6-11. PubMed ID: 20538322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression profile of renal cell carcinoma clear cell type.
    Dall'Oglio MF; Coelho RF; Leite KR; Sousa-Canavez JM; Oliveira PS; Srougi M
    Int Braz J Urol; 2010; 36(4):410-8; discussion 418-9. PubMed ID: 20815947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in molecular classification of renal neoplasms.
    Yin-Goen Q; Dale J; Yang WL; Phan J; Moffitt R; Petros JA; Datta MW; Amin MB; Wang MD; Young AN
    Histol Histopathol; 2006 Mar; 21(3):325-39. PubMed ID: 16372253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A three-gene expression signature model to predict clinical outcome of clear cell renal carcinoma.
    Yao M; Huang Y; Shioi K; Hattori K; Murakami T; Sano F; Baba M; Kondo K; Nakaigawa N; Kishida T; Nagashima Y; Yamada-Okabe H; Kubota Y
    Int J Cancer; 2008 Sep; 123(5):1126-32. PubMed ID: 18546273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic alterations in renal cell carcinoma with rhabdoid differentiation.
    Perrino CM; Hucthagowder V; Evenson M; Kulkarni S; Humphrey PA
    Hum Pathol; 2015 Jan; 46(1):9-16. PubMed ID: 25439741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WWOX protein expression varies among RCC histotypes and downregulation of WWOX protein correlates with less-favorable prognosis in clear RCC.
    Lin JT; Tzai TS; Liao CY; Wang JS; Wu TT; Wang HY; Wu CH; Yu CC; Lu PJ
    Ann Surg Oncol; 2013 Jan; 20(1):193-9. PubMed ID: 22555346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide gene expression profiles of clear cell renal cell carcinoma: identification of molecular targets for treatment of renal cell carcinoma.
    Hirota E; Yan L; Tsunoda T; Ashida S; Fujime M; Shuin T; Miki T; Nakamura Y; Katagiri T
    Int J Oncol; 2006 Oct; 29(4):799-827. PubMed ID: 16964377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tpl2 kinase impacts tumor growth and metastasis of clear cell renal cell carcinoma.
    Lee HW; Joo KM; Lim JE; Cho HJ; Cho HJ; Park MC; Seol HJ; Seo SI; Lee JI; Kim S; Jeong BC; Nam DH
    Mol Cancer Res; 2013 Nov; 11(11):1375-86. PubMed ID: 23982215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.